[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100463600":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":28,"collaborators":7,"id":30,"slug":31,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":35,"acronym":36,"eligibilityCriteria":37,"healthyVolunteers":32,"sex":38,"minAge":7,"maxAge":7,"enrollmentInfo":39,"targetDuration":7,"studyType":42,"phases":7,"briefSummary":43,"conditions":44,"keywords":7,"overallStatus":16,"whyStopped":7,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":56},{"fullName":5,"class":6},"Peking University First Hospital","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Yang Wang, Doctor","CONTACT","008613811232795","yangwang_dr@bjmu.edu.cn",[15],{"facility":5,"status":16,"city":17,"state":7,"zip":7,"country":18,"countryCode":19,"cosmosGeoPoint":20,"geoPoint":25,"contacts":26},"RECRUITING","Beijing","China","CN",{"type":21,"coordinates":22},"Point",[23,24],116.39723,39.9075,{"lat":24,"lon":23},[27],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"type":29,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100463600","china-type-ii-inflammatory-skin-disease-clinical-research-and-standardized-diagnosis-and-treatment-project-100463600",false,"NCT05316805","China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project","China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project: a National Multicenter Prospective Cohort Study","CORNERSTONE","Inclusion Criteria:\n\n1. Patients from the medical units that has passed the data review of the National Clinical Center for Skin and Immune Diseases (see the study sites for data collection for details);\n2. patients diagnosed with type 2 inflammatory skin diseases (dermatitis\u002Feczema, urticaria, pemphigoid, prurigo nodularis).\n\nExclusion Criteria:\n\n1. patients who fail to provide informed consent form;\n2. patients who cannot complete the questionnaire independently or under the guidance of investigators","ALL",{"count":40,"type":41},100000,"ESTIMATED","OBSERVATIONAL","In order to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases, the National Clinical Center for Skin and Immune Diseases established a standardized diagnosis and treatment center for type 2 inflammatory skin diseases to systematically and effectively understand the current treatment status of patients with type 2 inflammatory skin diseases, as well as the efficacy and safety of various treatment methods during practices, so as to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases and help patients with type 2 inflammatory skin diseases.",[45,46],"Atopic Dermatitis Eczema","Prurigo Nodularis","2024-08-13",{"date":49,"type":50},"2024-08-15","ACTUAL",{"date":52,"type":50},"2021-08-31",{"date":54,"type":41},"2031-12-31",{"name":5,"class":6},1]